Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 8/20 | 0.45 |
| ▸ | CNR2 | P34972 | 5/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | PPARA | Q07869 | 1/20 | 0.41 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.41 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.38 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 1/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.37 |
| ▸ | RXRA | P19793 | 1/20 | 0.37 |
| ▸ | PPARG | P37231 | 1/20 | 0.37 |
| ▸ | OXER1 | Q8TDS5 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11296642 | 0.88 | ALDH1A1 (0.45) | CNR1CNR2ALDH1A1TAS1R3TAS1R1 | |
| SCHEMBL9943892 | 0.86 | TAS1R3 (0.53) | CNR1CNR2ALDH1A1TAS1R3TAS1R1 | |
| SCHEMBL4396718 | 0.85 | CNR1 (0.57) | CNR1CNR2 | |
| SCHEMBL4888803 | 0.84 | CNR1 (0.47) | CNR1CNR2ALDH1A1PPARATAS1R3 | |
| SCHEMBL3951480 | 0.84 | CNR1 (0.47) | CNR1CNR2ALDH1A1PPARATAS1R3 | |
| SCHEMBL302274 | 0.84 | CNR1 (0.47) | CNR1CNR2ALDH1A1PPARATAS1R3 | |
| SCHEMBL1916650 | 0.80 | CNR2 (0.60) | CNR1CNR2PPARATRPA1TRPV1 | |
| SCHEMBL1916808 | 0.80 | CNR2 (0.60) | CNR1CNR2PPARATRPA1TRPV1 | |
| SCHEMBL1916306 | 0.80 | CNR2 (0.60) | CNR1CNR2PPARATRPA1TRPV1 | |
| SCHEMBL1916445 | 0.80 | CNR2 (0.60) | CNR1CNR2PPARATRPA1TRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1473287-A2 | Alkyldienamides exhibiting taste and sensory effect in flavor compositions | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2004-11-03 | — | — | EP | claimed |
| US-20040202619-A1 | Alkyldienamides exhibiting taste and sensory effect in flavor compositions | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2004-10-14 | — | — | US | claimed |
| US-7632531-B2 | Alkyldienamides exhibiting taste and sensory effect in flavor compositions | International Flavors & Fragnances Inc. (US) | 2009-12-15 | — | — | US | disclosed |
| EP-1473287-B1 | Alkyldienamides exhibiting taste and sensory effect in flavor compositions | INT FLAVORS & FRAGRANCES INC (US) | 2006-06-21 | — | — | EP | disclosed |
| EP-1473287-A2 | Alkyldienamides exhibiting taste and sensory effect in flavor compositions | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2004-11-03 | — | — | EP | disclosed |
| US-20040202619-A1 | Alkyldienamides exhibiting taste and sensory effect in flavor compositions | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2004-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040202619-A1 | Alkyldienamides exhibiting taste and sensory effect in flavor compositions | TAS2R5, TAS2R4, TAS2R3 | CNR1 870/4885CNR2 456/4885ALDH1A1 3165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.